Cargando…
Between-Batch Bioequivalence (BBE): a Statistical Test to Evaluate In Vitro Bioequivalence Considering the Between-Batch Variability
Bioequivalence testing is an essential step during the development of generic drugs. Regulatory agencies have drafted recommendations and guidelines to frame this step but without finding any consensus. Different methodologies are applied depending on the geographical region. For instance, in the EU...
Autores principales: | Bodin, Jonathan, Liandrat, Stéphanie, Kocevar, Gabriel, Petitcolas, Céline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651657/ https://www.ncbi.nlm.nih.gov/pubmed/32910283 http://dx.doi.org/10.1208/s12248-020-00486-5 |
Ejemplares similares
-
Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch Variability
por: Burmeister Getz, Elise, et al.
Publicado: (2021) -
Batch‐to‐batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial
por: Burmeister Getz, E, et al.
Publicado: (2016) -
Between‐Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical Trial
por: Burmeister Getz, E, et al.
Publicado: (2016) -
Quantitative methods and modeling to assess COVID‐19‐interrupted in vivo pharmacokinetic bioequivalence studies with two reference batches
por: Gong, Yuqing, et al.
Publicado: (2022) -
Bioequivalence: tried and tested
por: Schall, Robert, et al.
Publicado: (2010)